153.30

4.86% 7.10

After Hours: 153.30

Iqvia Holdings Inc (IQV)

Overview News Price History Option Chain Financials Discussions Forecast

Iqvia Holdings Inc stock is traded at $153.30, with a volume of 2.88M. It is up +4.86% in the last 24 hours and up +0.19% over the past month. Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Previous Close:

$146.20

Open:

$149.6

24h Volume:

2.88M

Relative Volume:

1.64

Market Cap:

$27.00B

Revenue:

$15.41B

Net Income/Loss:

$1.37B

P/E Ratio:

20.44

EPS:

7.5

Net Cash Flow:

$2.11B

1W Performance:

-1.14%

1M Performance:

+0.19%

6M Performance:

-29.58%

1Y Performance:

-33.10%

1-Day Range:

$146.72

$153.69

1-Week Range:

$143.65

$156.31

52-Week Range:

$135.97

$252.88

Iqvia Holdings Inc Stock (IQV) Company Profile

Name

Iqvia Holdings Inc

Sector

Healthcare (1154)

Industry

Diagnostics & Research (57)

Phone

919-998-2000

Address

2400 ELLIS ROAD, DURHAM, NC

Employee

88,000

Twitter

@IQVIA_global

Next Earnings Date

2024-10-31

Latest SEC Filings

IQV's Discussions on Twitter

Compare IQV with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IQV Iqvia Holdings Inc	153.30	27.00B	15.41B	1.37B	2.11B	7.50
TMO Thermo Fisher Scientific Inc	407.85	161.94B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	193.09	142.65B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	486.61	34.79B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	107.52	30.67B	6.53B	1.26B	1.31B	4.35

Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-25-25	Downgrade	HSBC Securities	Buy → Hold
Apr-10-25	Downgrade	Barclays	Overweight → Equal Weight
Feb-03-25	Downgrade	BTIG Research	Buy → Neutral
Dec-20-24	Initiated	Stephens	Overweight
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-04-24	Initiated	RBC Capital Mkts	Outperform
Jul-24-24	Downgrade	Jefferies	Buy → Hold
Jun-06-24	Initiated	Goldman	Buy
Feb-26-24	Initiated	Leerink Partners	Outperform
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Feb-13-24	Initiated	BTIG Research	Buy
Nov-02-23	Downgrade	Robert W. Baird	Outperform → Neutral
Sep-06-23	Initiated	HSBC Securities	Buy
Mar-17-23	Initiated	Truist	Buy
Dec-06-22	Initiated	Cowen	Outperform
Nov-17-22	Downgrade	Citigroup	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Jul-15-22	Initiated	SVB Leerink	Outperform
May-24-22	Initiated	Guggenheim	Buy
Apr-29-22	Upgrade	Piper Sandler	Neutral → Overweight
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Aug-05-21	Resumed	Credit Suisse	Outperform
Apr-16-21	Upgrade	Stephens	Equal-Weight → Overweight
Mar-08-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-03-21	Initiated	Barclays	Overweight
Jul-07-20	Initiated	Stephens	Equal-Weight
Mar-02-20	Initiated	Deutsche Bank	Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Dec-13-19	Upgrade	CFRA	Sell → Hold
Nov-14-19	Upgrade	Wolfe Research	Peer Perform → Outperform
Jun-21-19	Upgrade	Mizuho	Neutral → Buy
May-28-19	Initiated	SVB Leerink	Outperform
Jan-18-19	Upgrade	Jefferies	Hold → Buy
Oct-09-18	Initiated	UBS	Buy
Oct-02-18	Reiterated	Robert W. Baird	Outperform
Jul-25-18	Upgrade	BofA/Merrill	Neutral → Buy
Jul-25-18	Reiterated	Stifel	Buy
Jul-03-18	Upgrade	Raymond James	Outperform → Strong Buy
Apr-13-18	Upgrade	Goldman	Neutral → Buy
Mar-07-18	Upgrade	SunTrust	Hold → Buy
Jan-19-18	Initiated	Evercore ISI	Outperform

View All

Iqvia Holdings Inc Stock (IQV) Latest News

04:30 AM

IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

04:30 AM

04:15 AM

IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13 - Business Wire

04:15 AM

12:09 PM

Barclays Lowers IQVIA Holdings (IQV) Price Target to $165 Amid Demand Concerns | IQV stock price - paginasiete.bo

12:09 PM

11:07 AM

IQVIA (IQV) Target Price Lowered by UBS, Rating Maintained | IQV Stock News - GuruFocus

11:07 AM

09:36 AM

IQVIA Holdings (IQV): Barclays Lowers Price Target to $165 | IQV Stock News - GuruFocus

09:36 AM

09:06 AM

Baird Adjusts Price Target on IQVIA Holdings to $161 From $195, Maintains Neutral Rating - marketscreener.com

09:06 AM

05:46 AM

Barclays Adjusts Iqvia (IQV) Price Target Amid Demand Concerns | IQV Stock News - GuruFocus

05:46 AM

02:26 AM